Metabolism-Clinical and Experimental

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	966
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	881
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	328
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	252
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	252
Editorial Board	189
Editorial Board	177
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	173
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	155
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	153
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	150
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	147
Corrigendum to “Emerging roles of arginine metabolism in skeletal health and disease” [Metabolism 2025 Nov 19:175:156451. / PMID: 41270967]	143
Sarcopenia does not have adverse effects on insulin sensitivity in women with obesity	138
Insulin Resistance: An APOE4 Equivalent for Human Cerebral Cortical Amyloid Deposition	127
Cost–Benefit Management of Insulin Resistance: Combination of Phentermine and a Flexible Weight Loss Strategy in the Era of GLP-1 Agonists. Visible Benefits Shown After Six Months of Treatment	123
The role of active vitamin D in preventing sarcopenia—Authors' reply	120
Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2	116
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	110
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta	108
PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis	103
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	102
Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders	99
Brown adipose tissue-derived metabolites and their role in regulating metabolism	99
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	89

PCSK9 in metabolism and diseases	86
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	84
Consensus statement on vitamin D role in metabolic health	83
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	82
Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	80
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	78
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	78
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	77
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	77
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	73
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	73
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	72
PDAP1 reprograms fatty acid metabolism and drives malignant transformation via HSPA8-Mediated ERK/MAPK activation in hepatocellular carcinoma	71
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	71
From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosis	71
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	70
Editorial Board	66
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	66
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	65
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	64
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	64
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	60
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis	60
Role of mitochondria in pathogenesis and therapy of renal fibrosis	60
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration	59
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	59
Editorial Board	58
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	58
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	58
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	58
Editorial Board	58
Editorial Board	58
NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ	57
Editorial Board	57
Insulin Resistance as Monitored by Dynamic Light Scattering of Whole Human Serum: An Ancillary Study of PREMIER	55
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts	55
Identifying proteins and pathways associated with multimorbidity in 53,026 adults	55
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016	55
The LS-IM score and its relation to direct measurements of insulin resistance	54
Clinical and Biochemical Characteristics of Children and Adolescents with Type 1 Diabetes in Mexico	53
Nutritional Management of Patients with Obesity in Critical Care	53
Corrigendum to “Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise” [Metabolism, Volume 168, July 2025, 156	51
Reply to letter regarding the article “Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage	50
NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy	49
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	49
Editorial Board	49
The heart rate paradox and inferential limits of the GLP-1 receptor agonist–atrial fibrillation association	49
Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment	48
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies	48
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at	46

Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism	46
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis	46
Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis	46
Calcitonin and procalcitonin: Revisiting the overlooked role of C cells	45
Best practice recommendations for the diagnosis and management of hypoparathyroidism	45
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	45
Editorial Board	43
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort	42
Association Between Processed and Ultra-processed Food Intake and Cardiovascular Disease and its Risk Factors in Patients with Type 2 Diabetes	42
New PET Measures of Functional Brain Fractal Dimensions Show Significant Differences for Cortical Grey and White Matter and also in Near Normal vs. Insulin Resistant Patients	41
Omentin-1 Levels and Endothelial Dysfunction in Diabetic Kidney Disease	41
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19	41
Commentary on the endocrine society clinical practice guideline on the “treatment of hypercalcemia of malignancy in adults”	40
Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications	39
Corrigendum to “The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans” [Metab. 97 (2019) 40–49]	39
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation	39
Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1	39
Response to letter to the editor regarding: “Plasma metabolite profiles of meat intake and their association with cardiovascular disease risk: A population-based study in Swedish cohorts” by Arage et	38
Mapping circulating microRNA signatures in type 1 diabetic microvascular disease: A systematic review and Bayesian multilevel meta-analysis with bioinformatic integration of molecular dysregulation	38
Folic acid mitigation of alcohol-induced sarcopenia via gut-muscle axis modulation	38
Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial	38
Editorial Board	38
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy	37
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes	37
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis	36
Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections	36
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection	36
Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis	36
The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions	35
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity	34
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases	34
Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver	34
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways	34
O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36	34
Interplay of lipid metabolism and inflammation in podocyte injury	33
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study	33
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation	33
C3aR1 on beta cells preserves beta cell function and glucose homeostasis in diabetic mice by decreasing metabolic stress and dedifferentiation	33
CSRP3 promotes skeletal muscle remodeling toward aerobic metabolism and enhances exercise endurance through increasing LDHD activity	32
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation - author's reply	32
Changes in Body Composition, Regional Fat Distribution, and Metabolism After Stopping Tirzepatide	32
The Role of Insulin Resistance in the Severity of PCOS Among a Population in Albania	32
Counter-Regulatory Hormone Oscillations, Substrate Competition and Accumulation in the Pathogenesis of Insulin Resistance: A Hypothesis	32
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients	32
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming	31
Effects of Semaglutide on Metabolic Syndrome Parameters in Non-Diabetics: A Meta-analysis of Randomized Controlled Trials	31
Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation	31
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis	31
Blood C-Peptide Values are Impacted by the Collection, Storage and Evaluation Methods	31
Sodium-dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled T	31
NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway	30
Copper impairs the intestinal barrier integrity in Wilson disease	30
Dyslipidemia Correction by Combination of Statin and Choline Fenofibrate in Diabetic Patients with Multifocal Atherosclerosis	30
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor	30
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study	30
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled	29
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response	29
The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression	29
Emerging roles of TRIM in metabolic regulation	29
METTL1-mediated m7G methylation of FoxO1 regulates lipid metabolism in metabolic dysfunction-associated fatty liver disease	29
Aging and metabolism in HFpEF: Pathophysiology and therapeutic implications	29
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?	28
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus	28
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank	28
Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence	28
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study	28
Propionyl-L-Carnitine in Patients with Type 2 Diabetes and Peripheral Artery Disease	28
Editorial Board	28
Myocardial Ischemia in Type 2 Diabetic Patients	28
Metabolomic aging clock predicts risk of different cardiovascular diseases in the UK Biobank	28
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets	27
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980]	27
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease	27
The Family Heart Foundation Cholesterol Connect® Program: Reducing Gaps in Cardiovascular Risk Factor Awareness through Free At-Home LDL-C and Lipoprotein(a) Screening and Support	27
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential	27
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD	27
The role of histone deacetylases in cardiac energy metabolism in heart diseases	27
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models	27
GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies	27
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	26

Reply to letter regarding the article “Loss of cardiomyocyte AKT signaling causes deterioration of lipid metabolism and cellular atrophy”	26
Clarifying the liver-brain MRI signal behind fibro-inflammatory liver injury	26
Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes	26
Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study	26
Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice	26
Thymoquinone: A Promising Anti-diabetic Molecule!	25
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	25
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and Cardiovascular Disease: Results from CATALYST	25
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	24
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	24
ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysis	24
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	24
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	24
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury	24
Primary cilia regulate adaptive responses to fasting	24
Effects Of Late Onset Estradiol Treatment On Insulin Resistance And Lipid Metabolism In High-Fat-Fed Ovariectomized Female Mice	24
Reply to: “Precision nutrition in aging: Enhancing frailty prevention through personalized dietary interventions”	24
Liver cancer chronically exposed to palmitate acquires ferroptosis resistance via the downregulation of glutamine-driven hepcidin expression	24
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	24
Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide	23
Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond	23
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	23
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	23
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	23
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	23
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	23
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	22
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	22
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	22
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	22
Reply to letter to the editor: Fracture-centered interpretation of antiresorptive therapy in men with prostate cancer receiving androgen deprivation therapy	22
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	22
Lysine potentiates insulin secretion via AASS-dependent catabolism and regulation of GABA content and signaling	22
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	22
A Rare Cause of Severe Insulin Resistance: A Case Report	22
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	22
Corrigendum to “Current and investigational medications for the treatment of sarcopenia” [Metabolism 2023;149:155597]	21
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy	21
FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase	21
Incretin-based therapy and atrial fibrillation risk in overweight or obesity	21
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies	21
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness	21
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner	21
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression	21
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	21
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice	21
The bone-heart axis: A crucial dialogue in cardiovascular disease	20
Intravital imaging reveals glucose-dependent cilia movement in pancreatic islets in vivo	20
Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances	20
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential	20
Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration	20
Meteorin-like protein inhibits vascular smooth muscle cell-derived foam cell formation and atherosclerosis via KIT- endoplasmic reticulum stress signaling	20
Time-restricted eating and its impact on weight loss, adipose tissue distribution, lean mass and blood pressure in women with cardiometabolic risk factors	19
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma	19
COVALENT-111: Durable Glycemic and C-Peptide Improvements with Icovamenib, a Menin Inhibitor Targeting β-Cell Restoration in Insulin-Deficient Type 2 Diabetes	19
Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitis	19
Insulin Resistance Probability Score and Cardiovascular Events in the Elderly	19
Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise	19
Circulating Total and Intact GDF-15 Levels are Not Altered in Response to Weight Loss Induced by Liraglutide and/or Lorcaserin Treatment in Humans with Obesity and/or Diabetes	19
Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019	19
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States	19
Editorial Board	19
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway	19
Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy	19
Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice	19
ALDH2 variants – a role in cardiometabolic syndrome	18
Aldosterone Dysregulation and Type 2 Diabetes Mellitus Are Associated with Prevalent Risk of Hypertension: BREAKTHROUGH Risk Study	18
Editorial Board	18
Corrigendum to “Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1” [Metabolism, Volume 163 (2025), Article Number 156087]	18
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation	18
The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis	18
Impact of Insulin Resistance and Chronic Low-Grade Systemic Inflammation on Vascular Rigidity in Patients with Arterial Hypertension and Non-Alcoholic Fatty Liver Disease	18
Adiponectin Gene Variants and their Association with Homa-Index, Adiponectin and Leptin Levels in Adult Metabolic Syndrome Women	18
Induction of Yin Yang 1 (YY1) overexpression in mature adipocytes promotes dysfunctional adipose tissue and systemic insulin resistance in mice	18
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity	18
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss	18
Long Term Effectiveness of the Latest Categories of Antidiabetic Medication for Type 2 Diabetes. Outcomes of the Outpatient Diabetic Clinic of a Tertiary Hospital of Athens	18
A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study	18
The intersection of exercise, nitric oxide, and metabolism: Unraveling the role of eNOS in skeletal muscle and beyond	17
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα	17
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives	17
Mechanical activation of adipose tissue macrophages mediated by Piezo1 protects against diet-induced obesity by regulating sympathetic activity	17
Glycine as a conditionally essential amino acid and its relationship to l-serine	17
Metabolaging: a new geroscience perspective linking aging pathologies and metabolic dysfunction	17
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance	17
IFT80 and TRPA1 cooperatively regulate bone formation by calcium signaling in response to mechanical stimuli	17
Essential role of endothelial T-cadherin in the transcytosis of circulating high-molecular-weight adiponectin to sub-vascular tissues	17
Corrigendum to “Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study” [Metabolism, Volume 152, March 2024, 155789]	17
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-I	17
Metabolomics profiles of type 2 diabetes and insulin resistance and their associations with total mortality	17
Reply to letter to the editor: Circadian robustness and glycemic control: From wearable data to clinical implications	17